课题基金 / 基金详情

Developing an anti-HIV drugs that inhibit uncoating for overcomingdrug resistance

Developing an anti-HIV drugs that inhibit uncoating for overcomingdrug resistance
开发一种抗艾滋病毒药物,通过抑制脱衣来克服耐药性
批准号:
23659066
负责人:
MISUMI Shogo
金额:
$2.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Exploratory Research
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2012

项目摘要

项目成果

MISUMI Shogo的其他基金

相似基金

相关文献

中文摘要
翻译
我们以前报道过Pin 1通过磷酸化的Ser 16-Pro 17基序与衣壳(CA)核心相互作用,促进人类免疫缺陷病毒1型(HIV-1)的脱壳。然而,负责Ser 16磷酸化的特定激酶仍然未知。在这里,我们表明,病毒体相关的胞外信号调节激酶2(ERK 2)磷酸化丝氨酸16。将CEM/LA V-1细胞暴露于10 μM沙奎那韦和HIV-1蛋白酶的D25 N失活突变体中产生的不成熟病毒粒子的特征表明,Ser 16在Pr 55 gag加工开始后被磷酸化。此外,基于质谱的体外激酶分析表明,ERK 2特异性磷酸化Ser 16-Pro 17基序的底物中的Ser 16残基。用ERK 2抑制剂sc-222229处理CEM/LA V-1细胞后,病毒颗粒内Ser 16磷酸化水平降低,Ser 16磷酸化部分缺陷的病毒由于减弱了Pin 1依赖性脱包被而表现出逆转录受损和复制减弱。RNA干扰抑制CEM/LA V-1细胞中ERK 2的表达,可抑制病毒颗粒内ERK 2的包装,降低病毒颗粒内丝氨酸16的磷酸化水平。有趣的是,ERK 2包装缺陷病毒显示逆转录受损和HIV-1复制减弱。总之,这些发现提供了对Pin 1依赖的HIV-1去包被过程的深入了解。
英文摘要
We previously reported that Pin1 facilitates the humanimmunodeficiency virus type 1 (HIV -1) uncoating by interacting with the capsid (CA) corethrough the phosphorylated Ser16-Pro17motif. However , the specific kinase responsible forSer16phosphorylation has remained unknown. Here, we show that virion-associatedextracellular signal-regulated kinase 2 (ERK2) phosphorylates Ser16. The characterization ofimmature virions produced by exposing of CEM/LA V -1 cells to 10 μM saquinavir and a D25Ninactive mutant of HIV -1 protease indicated that Ser16is phosphorylated after the initiationof Pr55gagprocessing. Furthermore, a mass spectrometry-based in vitro kinase assaydemonstrated that ERK2 specifically phosphorylated the Ser16residue in theSer16-Pro17-motif-containing substrate. The treatment of CEM/LA V -1 cells with the ERK2inhibitor sc-222229 decreased the Ser16phosphorylation level inside virions, and the viruspartially defective in Ser16phosphorylation showed an impaired reverse transcription and anattenuated replication owing to an attenuated Pin1-dependent uncoating. Furthermore, thesuppression of ERK2 expression by RNA interference in CEM/LA V -1 cells resulted insuppressed ERK2 packaging inside virions and decreased the Ser16phosphorylation levelinside virions. Interestingly , the ERK2-packaging-defective virus showed an impaired reversetranscription and an attenuated HIV -1 replication. Taken together , these findings provideinsights into the as yet obscure processes in Pin1-dependent HIV -1 uncoating.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIV-1カプシド蛋白質Ser16リン酸化による脱殻素過程の制御機構
HIV-1衣壳蛋白Ser16磷酸化控制脱落过程的机制
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [堂地 赳生, 井上 睦美, 高宗 暢暁, 庄司 省三, 杉本 幸彦, 三隅 将吾]
通讯作者: 三隅 将吾
HIV 脱殻過程を制御する HIV カプシドタンパク質リン酸化機構の解明
阐明控制 HIV 脱落过程的 HIV 衣壳蛋白磷酸化机制
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [堂地 赳生, 高宗 暢暁, 庄司 省三, 杉本 幸彦, 三隅 将吾]
通讯作者: 三隅 将吾
ERK2によるHIV CAのSer16リン酸化を介した脱殻制御機構に関する解析
ERK2对HIV CA Ser16磷酸化介导的脱落控制机制分析
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [堂地 赳生, 高宗 暢暁, 庄司 省三, 杉本 幸彦, 三隅 将吾]
通讯作者: 三隅 将吾
Induction of extremely low protein expression level by fusion of C-terminal region of Nef.
通过 Nef C 末端区域的融合诱导极低的蛋白质表达水平。
DOI: 10.1002/bab.1021
发表时间: 2012
期刊: Biotechnology and Applied Biochemistry
影响因子: 2.8
作者: [Takamune, N. *, Irisaka, Y., Yamamoto, M., Harada, K., Shoji, S., Misumi, S.]
通讯作者: S.
14
    Exploration of cellular host factor required for HIV-1 infection and approaches to overcome multi-drug resistant HIV-1
    • 批准号:
      24390032
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2012
    • 负责人:
      MISUMI Shogo
    • 依托单位:
    Development of the next generation of AIDS vaccine candidates based on the immune response of HIV-resistant individuals.
    • 批准号:
      21390035
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2009
    • 负责人:
      MISUMI Shogo
    • 依托单位:
    Development of Novel Oral Vaccine Delivery System for Mucosal Immunization in Gut-Associated Lymphoid Tissue
    • 批准号:
      19790063
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.42万
    • 财政年份:
      2007
    • 负责人:
      MISUMI Shogo
    • 依托单位:
    海外基金